Services
How engagements work
Four practice areas, one operating model: a senior practitioner does the work, the client sees the reasoning, and the engagement ends with a decision rather than an options matrix.
Commercial strategy
For companies moving an asset from development toward commercialisation. We build the commercial thesis and stress-test it — who the asset competes with, which patient population it realistically serves, how payers are likely to respond, and what the launch sequence should be.
Typical deliverables include a positioning framework, a pricing and market access strategy, a product portfolio prioritisation, and a launch readiness assessment. Engagements run six to twelve weeks.
Market and competitive assessment
A structured read of a defined therapeutic area: what is approved, what is in development, where the genuine unmet need sits, and how large the addressable opportunity is under stated assumptions. We show the assumptions and the sensitivity around them, because the assumptions are usually the argument.
Engagements run four to eight weeks.
Commercial due diligence
Independent assessment of a development-stage asset or pipeline for corporate clients evaluating a licensing deal, a partnership, or a corporate development transaction. We assess the commercial case on its merits and say plainly where the evidence is thin.
This is advisory work for corporate decision-makers. It is not investment advice, it is not a valuation opinion offered to investors, and Biophic takes no position in any asset or company it assesses. Engagements run three to six weeks and move faster when a transaction timeline requires it.
Scientific translation
Sometimes the need is narrower: a management team has a body of biophysical, preclinical, or early clinical evidence and needs it rendered into commercial language for a board, a partner, or an internal committee. We read the primary data and write the argument, including the parts that weaken it.
Engagements run two to four weeks.
Working with us
| Clients | Pharmaceutical and biotechnology companies, and their corporate development and commercial teams. We work with organisations, not with individual patients or consumers. |
|---|---|
| Engagement length | Two to twelve weeks depending on the practice area. |
| Team | Senior-led. The person you meet is the person doing the work. |
| Confidentiality | All engagements operate under a mutual non-disclosure agreement executed before any material is exchanged. |
| Getting started | An introductory call, typically thirty minutes, to establish whether the question is one we can usefully answer. Request one here. |
Scope of our services
Biophic LLC provides strategic advisory services to corporate clients in the pharmaceutical and biotechnology industries. Biophic does not develop, manufacture, distribute, dispense, or sell any drug, medical device, or medical product, and does not provide medical advice or clinical care to individuals.
Biophic does not provide investment advice or securities recommendations, does not solicit or manage investments, and is not a registered investment adviser or a broker-dealer. Biophic does not collect or process patient health information.